ARCHIVES

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 03 | January 17, 2003

Download PDF Visit The Full Archive

Related Articles

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

NCI Picks Duke To Lead caBIG’s Knowledge Center For Clinical Trials.

July 3, 2008

In Brief: Minna to Leave NCI For Texas Southwestern; Alexander Is Special Populations Branch Chief

February 22, 1991

Cech To Step Down At HHMI In 2009.

April 18, 2008

Construction Report Scheduled for NCAB

August 25, 1978

Guest Editorial “Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot

September 26, 2014